市場調查報告書
商品編碼
1235931
全球生物保存市場:到 2028 年的預測 - 按產品類型、生物標本、技術、應用、最終用戶、地區分類Biopreservation Market Forecasts to 2028 - Global Analysis By Type, By Biospecimen, By Product, By Technology, By Application, By End User and By Geography |
根據 Stratistics MRC 的數據,2022 年全球生物保存市場將達到 20.6 億美元,預計到 2028 年將達到 85.9 億美元,預測期內增長 269 億美元。以復合年增長率增長的 %。
為了保存生物材料,天然植物及其抗菌化合物被用於生物保存過程。 生物保存在醫療保健和食品行業中對於生物材料和食品的長期保存極為重要。
根據美國食品和藥物管理局 (FDA) 的數據,該機構在 2017 年批准了 16 種個性化藥物,佔批准藥物總數的 20%。
在預測期內,生物樣本庫的增加預計將推動生物保存市場的擴張。 例如,美國紐約長老會醫院和哥倫比亞大學 Vagueros 內外科於 2020 年 3 月作為哥倫比亞大學和其他研究人員收集、存儲和分發生物標本和臨床數據的集中存儲庫。建立了 COVID-19 生物樣本庫。
據估計,開發能夠在室溫下保存生物標本的介質解決方案會阻礙全球生物保存行業的發展。 例如,室溫樣品穩定介質如 DNA Stable 和 RNA Stable 可從 Biomatrica, Inc. 獲得。 這些替代品通過降低對冰櫃和冰箱的需求來限制市場擴張。
憑藉來自風險投資、政府和家長團體以及患者教育的充足資金,全球生物保存市場的參與者有望從極具吸引力的擴張潛力中受益。. 此外,全球生物保存市場的參與者在中國、巴西、印度、東歐、中東和拉丁美洲等快速發展的新興國家擁有巨大的機會。 這些地區的經濟增長增加了可支配收入,從而增加了人口的購買力。
行業格局在很大程度上受到環境存儲技術需求的限制。 例如在美國,疫苗每年可挽救約 300 萬人的生命,但冷藏和儲存不當會損壞或浪費價值約 2000 萬美元的疫苗。 冷凍和解凍造成的組織和細胞損傷是一種常見的副作用,破壞了市場的可持續性。
COVID-19 產生了重大影響,因為製藥和生物技術公司的研發工作已經擴展到製造和生產需要生物保存的疫苗。 由於與產品消費減少相關的供需鏈中斷,COVID-19 大流行對生物防腐業務產生了負面影響。 然而,隨著冠狀病毒病例數量下降而解除限制,對 COVID-19 疫苗和療法的需求激增,推動了行業的全面增長。
預計再生醫學在預測期內將佔據最大份額,因為它可以再生、替換和修復因疾病、損傷或衰老而受損的組織和器官。 這些藥物可以幫助細胞和組織正常運作,並用於治療各種退行性疾病,包括皮膚病、神經病、心血管病和骨科疾病。
作為生物保存過程不可或缺的一部分,生物保存介質部分預計在整個預測期內將以有利的複合年增長率增長。 此外,調查、診斷、監測和治療健康障礙的能力預計將在預測期內推動市場發展,而媒體應用程序的功能和細節將得到增強,使研究人員能夠訪問和交換研究分析和數據。 .
各種實驗室、病理中心和醫院的血液和實體組織標本的保存,包括腫瘤和其他組織(如外周血細胞、骨髓、臍帶血及其衍生物)的石蠟包埋或冷凍生物標本。由於需求,預計北美地區將在預測期內隨著需求的增加而主導市場。
由於生物醫學研究的進步和尖端療法的開發,預計北美在預測期內將實現利潤豐厚的增長。 此外,由於需要治療的慢性病發病率不斷上升,該地區的市場佔有率得到加強。 預計此類企業將通過增加市場上可用的生物防腐產品的種類來支持增長。 此外,預計在預測期內,美國政府機構和其他生物銀行機構將大量採用生物保存技術。
生物保存市場的主要參與者是: Biomatrica, Inc.、Azenta Us, Inc.、Mve Biological Solutions、Biolife Solutions、Labvantage Solutions, Inc.、Taylor-Wharton、Thermo Fisher Scientific, Inc.、Panasonic Corporation、Princetoncryo、X-Therma Inc. p>
2022 年 10 月,Azenta, Inc. 收購了 B Medical Systems S.a r.l. 及其子公司,B Medical Systems S.a r.l. 是一家溫控存儲和運輸解決方案提供商,可在全球範圍內提供救生護理。
2022 年 7 月,Cellutions BioStorage 是一家從研究到推出的低溫保存庫,在印度金奈推出。 它是一家提供全方位服務的生物材料存儲和物流供應商,與希望在整個產品生命週期過程中外包供應鏈管理各個方面的生物製藥公司合作。 最近開放的設施擁有 25,000 平方英尺的一流基礎設施。
購買此報告的客戶將免費獲得以下定制之一。
根據產品組合、地理分佈和戰略聯盟對主要參與者進行基準測試
According to Stratistics MRC, the Global Biopreservation Market is accounted for $2.06 billion in 2022 and is expected to reach $8.59 billion by 2028 growing at a CAGR of 26.9% during the forecast period. In order to preserve biological material, natural flora and its antimicrobial compounds are used in the process of biopreservation. In order to maintain biological material or food products for an extended period of time, biopreservation is crucial in the healthcare and food industries.
According to the US Food and Drug Administration (FDA), The department has approved 16 personalized medicines in the year 2017, which accounts for 20% of total drug approvals.
Over the forecast period, an increase in biobanks is anticipated to fuel market expansion for biopreservation. For instance, the New York-Presbyterian Hospital and Columbia University Vagelos College of Physicians and Surgeons in the United States established the COVID-19 Biobank in March 2020 as a centralised repository for the collection, storage, and distribution of biological specimens and clinical data for researchers at Columbia University and elsewhere.
The development of media solutions that permit the storage of biospecimens at room temperature is estimated to hamper the expansion of the global biopreservation industry. For instance, room-temperature sample stabilisation media such as DNA Stable and RNA Stable are provided by Biomatrica, Inc. Such alternatives limit market expansion by jeopardising the demand for freezers and refrigerators.
Players in the worldwide biopreservation market might anticipate benefiting from attractive expansion potential if sufficient funding is made accessible from venture capitalists, governments, or parent organisations, coupled with patient education. Additionally, players in the global biopreservation market have a huge amount of opportunity in new and fast-growing countries like China, Brazil, India, Eastern Europe, the Middle East, and Latin America. This is because economic growth in these regions has given the population greater purchasing power because disposable incomes have increased.
The industry landscape is significantly constrained by the need for room temperature storage technologies. In the United States, for instance, vaccines save around 3 million lives a year; however, due to improper refrigeration and storage, vaccines worth about 20 million dollars are damaged or dumped. Tissue or cell damage from freezing and thawing is a common side effect, which is harming the market's sustainability.
Due to the expanded efforts in research and development by pharmaceutical and biotech businesses to produce and manufacture a vaccine that required biopreservation, COVID-19 had a significant impact. Due to the disruption in the supply and demand chains caused by the decline in product consumption, the COVID-19 pandemic had a negative impact on the biopreservation business. However, the demand for the COVID-19 vaccine and treatment medicines surged as a result of the limits being removed as a result of the decrease in coronavirus cases, which fueled the growth of the industry across the board.
During the projection period, regenerative medicines are anticipated to account for the largest share because they can regenerate, replace, and repair tissues and organs that are damaged by disease, injury, or the ageing process. These medications can help cells and tissues function properly and are used to treat a variety of degenerative conditions, including dermatology, neurological diseases, cardiovascular conditions, and orthopaedic situations.
Because it is an integral part of the biopreservation process, the biopreservation media segment is anticipated to rise at a lucrative CAGR throughout the forecast period. Additionally, the ability to investigate, diagnose, monitor, and treat health disorders-which are expected to drive the market in the forecast period-is improved by media apps' increased features and details that enable researchers to access and exchange research analysis and data.
Due to the demand for the preservation of blood and solid tissue specimens, including paraffin-embedded or frozen bio-specimens of tumours and other tissues (like peripheral blood cells, bone marrow, and cord blood and its derivatives), across various research institutes, pathological centres, and hospitals, the demand is expected to increase during the projection period, and the North American region is expected to dominate the market.
Because of the rise in biomedical research and the development of cutting-edge therapeutics, North America is predicted to have lucrative growth over the projection period. Additionally, the region's market presence is strengthened by the increased occurrence of chronic diseases that require therapies. Such operations are anticipated to support growth by expanding the variety of biopreservation products accessible on the market. Moreover, the penetration of biopreservation techniques is expected to increase significantly in the U.S. during the projection period as a result of government agencies and other biobanking institutions.
Some of the key players in Biopreservation market Include: Biomatrica, Inc., Azenta Us, Inc., Mve Biological Solutions, Biolife Solutions, Labvantage Solutions, Inc., Taylor-Wharton, Thermo Fisher Scientific, Inc., Panasonic Corporation, Princetoncryo, X-Therma Inc., Stirling Ultracold.
In October 2022, Azenta, Inc. acquired B Medical Systems S.a r.l and its subsidiaries, a provider of temperature-controlled storage and transportation solutions that enables the delivery of life-saving treatments across the globe.
In July 2022, Cellutions BioStorage, a research-to-launch Cryopreservation Bank, was inaugurated in Chennai, India. It is a full-service biomaterial storage and logistics provider that works with biopharmaceutical firms looking to outsource all aspects of supply chain management throughout the course of a product's life cycle. The recently-launched facility is spread over 25,000 square feet and has top-notch infrastructure.
All the customers of this report will be entitled to receive one of the following free customization options:
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances